Web9 Apr 2024 · Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Rating) has earned an average rating of "Buy" from the six brokerages that are presently covering the company, MarketBeat Ratings reports.Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have updated their coverage on the stock in … Web12 Dec 2014 · Stanford University. Mar 2008 - Feb 20157 years. Studied genetic and chemical modulation of cell fate in response to genotoxic stress, somatic reprogramming to pluripotency, and Wnt signaling ...
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average …
WebTenaya Therapeutics Smolensk State Medical Academy, Medical Faculty, the Doctor of the general practice Acerca de +15 years international … WebTenaya Therapeutics. Feb 2024 - Feb 20242 years 1 month. South San Francisco, California, United States. Responsible for the development of a GMP, clinical manufacturing plant from planning ... redguard alternative
Natalia Paterson-Sonicheva - Senior Director Medical …
WebTenaya Therapeutics. Alabama State University. Report this profile Report Report. Back Submit. About I am an Associate Scientist working mainly in process development/tech … WebLinkedIn View on LinkedIn Dr. Hoey is chief scientific officer at Tenaya Therapeutics, where he is responsible for directing research to develop novel agents for treating heart disease. Prior to Tenaya, he directed preclinical research and drug development as senior vice president and co-chief scientific officer at OncoMed Pharmaceuticals. Dr. WebTenaya Therapeutics Jan 2024- Present1 year 2 months South San Francisco, California, United States Liaison to staff, vendors, business … redguard bookcase piled